We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » U.S. Trails Europe in Getting Patient Perspective in Drug Development
U.S. Trails Europe in Getting Patient Perspective in Drug Development
The FDA is taking steps toward getting more patient input during the drug development process, a move that puts the agency more in line with its EU counterparts, agency officials said June 18 at the DIA annual meeting in Washington, D.C.